| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.052 | 0.4 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |